|
⚲
|
| Keyboard |
| Vensana Capital I GP LLC
✚
|
|
|---|---|
| CIK # | 0001854073 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001854073] | |
| 4 | [0001854073] | |
| SC 13D | [0001854073] | |
| SC 13G | [0001854073] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Vensana Capital I GP LLC | Spyglass Pharma Inc | [2026-02-10] |
| Vensana Capital I GP LLC | CVRX Inc | [2022-02-10] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Nielsen Kirk G | |
| SpyGlass Pharma Inc | |
| Vensana Capital Management LLC | |
| Vensana Capital I GP LLC | |
| Klein Peter Justin |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
SpyGlass Pharma Inc SGP
Common Stock
|
2026-02-09 | Conversion | 548,067 | ||
|
SpyGlass Pharma Inc SGP
Common Stock
|
2026-02-09 | Buy | 165,000 | $16.00 | 2,640,000 |
|
SpyGlass Pharma Inc SGP
Common Stock
|
2026-02-09 | Conversion | 359,255 | ||
|
SpyGlass Pharma Inc SGP
Common Stock
|
2026-02-09 | Conversion | 1,690,230 | ||
|
SpyGlass Pharma Inc SGP
Common Stock
|
2026-02-09 | Conversion | 548,067 | ||
|
SpyGlass Pharma Inc SGP
Series C-2 Preferred Stock · derivative
|
2026-02-09 | Conversion | 3,142,015 | ||
|
SpyGlass Pharma Inc SGP
Series D Preferred Stock · derivative
|
2026-02-09 | Conversion | 2,059,573 | ||
|
SpyGlass Pharma Inc SGP
Series C-1 Preferred Stock · derivative
|
2026-02-09 | Conversion | 3,142,015 | ||
|
SpyGlass Pharma Inc SGP
Series B Preferred Stock · derivative
|
2026-02-09 | Conversion | 9,689,922 |